Back to Search
Start Over
EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.
- Source :
-
Nature clinical practice. Oncology [Nat Clin Pract Oncol] 2006 Apr; Vol. 3 (4), pp. 170-1. - Publication Year :
- 2006
- Subjects :
- Clinical Trials as Topic
Drug Delivery Systems
ErbB Receptors biosynthesis
ErbB Receptors genetics
Erlotinib Hydrochloride
Gefitinib
Gene Dosage
Humans
Protein Kinase Inhibitors therapeutic use
Quinazolines therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
Carcinoma, Non-Small-Cell Lung genetics
ErbB Receptors antagonists & inhibitors
Genes, erbB-1
Lung Neoplasms drug therapy
Lung Neoplasms genetics
Mutation
Subjects
Details
- Language :
- English
- ISSN :
- 1743-4254
- Volume :
- 3
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Nature clinical practice. Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 16596125
- Full Text :
- https://doi.org/10.1038/ncponc0476